The development of clinical activity in relapsing–remitting MS is associated with a decrease of FasL mRNA and an increase of Fas mRNA in peripheral blood

✍ Scribed by Luba Lopatinskaya; Anette H.H. van Boxel-Dezaire; Frederik Barkhof; Chris H. Polman; Cornelis J. Lucas; Lex Nagelkerken

• Book ID: 114137910
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 409 KB
• Volume: 138
• Category: Article
• ISSN: 0165-5728
• DOI: 10.1016/s0165-5728(03)00089-4